PLYMOUTH MEETING, Pa., Oct. 21, 2016-- Inovio Pharmaceuticals, Inc., today announced that its President and Chief Executive Officer, Dr. J. Joseph Kim, has been selected as a 2016 Healthcare Innovator ...
- Capital Cube•3 days ago
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Inovio Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to INO-US. Comparing the performance and risk of Inovio Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
- Motley Fool•9 days ago
Bluebird uses viruses to fight rare diseases. Inovio fights diseases caused by viruses. Which of these biotechs is the better pick for investors?
Inovio Pharmaceuticals, Inc. (INO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||8.33 x 100|
|Ask||8.75 x 10200|
|Day's Range||8.25 - 8.47|
|52wk Range||4.50 - 11.69|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-15.28|
|Avg Vol (3m)||1,173,341|
|Dividend & Yield||N/A (N/A)|